{
  "DOI": "10.1007/s12687-019-00430-x",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-019-00430-x",
  "alternative-id": [
    "430"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "6 August 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 July 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "16 August 2019"
    },
    {
      "group": {
        "label": "Compliance with ethics standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Erika Kleiderman declares that she has no conflict of interest.Ian Stedman is a former member of the Board of Directors of the Canadian Organization for Rare Disorders and a member of the Working Group on Rare Disease Research (Rare Disease International)."
    },
    {
      "group": {
        "label": "Human and animal rights and informed consent",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This article does not contain any studies with human participants or animals performed by any of the authors."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-0242-2296",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kleiderman",
      "given": "Erika",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Stedman",
      "given": "Ian Norris Kellner",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        8,
        16
      ]
    ],
    "date-time": "2019-08-16T08:02:43Z",
    "timestamp": 1565942563000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        8,
        14
      ]
    ],
    "date-time": "2020-08-14T23:29:26Z",
    "timestamp": 1597447766000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T09:41:02Z",
    "timestamp": 1700646062119
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        8,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            16
          ]
        ],
        "date-time": "2019-08-16T00:00:00Z",
        "timestamp": 1565913600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            16
          ]
        ],
        "date-time": "2019-08-16T00:00:00Z",
        "timestamp": 1565913600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-019-00430-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-019-00430-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-019-00430-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "129-138",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        8,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        8,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "V Alonso",
      "first-page": "11",
      "journal-title": "Georgian Med News",
      "key": "430_CR1",
      "unstructured": "Alonso V, Villaverde-Hueso A, Hens M, Morales-Piga A, Abaitua I, de la Paz Posada M (2011) Public health research on rare diseases. Georgian Med News 193:11–16",
      "volume": "193",
      "year": "2011"
    },
    {
      "DOI": "10.2105/ajph.89.11.1649",
      "author": "A Asch",
      "doi-asserted-by": "publisher",
      "first-page": "1649",
      "journal-title": "Am J Public Health",
      "key": "430_CR2",
      "unstructured": "Asch A (1999) Prenatal diagnosis and selective abortion: a challenge to practice and policy. Am J Public Health 89:1649–1657. \nhttps://doi.org/10.2105/ajph.89.11.1649",
      "volume": "89",
      "year": "1999"
    },
    {
      "key": "430_CR3",
      "unstructured": "Assisted Human Reproduction Act, SC 2004, c.2"
    },
    {
      "key": "430_CR4",
      "unstructured": "Baltimore D et al. (2018) Statement by the Organizing Committee of the Second International Summit on Human Genome Editing. \nhttp://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=11282018b\n\n. Accessed 29 November 2018"
    },
    {
      "DOI": "10.1086/677021",
      "author": "E Barnes",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "journal-title": "Ethics",
      "key": "430_CR5",
      "unstructured": "Barnes E (2014) Valuing disability, causing disability. Ethics 125:88–113",
      "volume": "125",
      "year": "2014"
    },
    {
      "key": "430_CR6",
      "unstructured": "Barrera LA, Galindo GC (2010) Ethical aspects on rare diseases. In: Rare Diseases Epidemiology. Springer, pp 493–511"
    },
    {
      "DOI": "10.1186/s13023-016-0462-7",
      "doi-asserted-by": "publisher",
      "key": "430_CR7",
      "unstructured": "Baynam G, Pachter N, McKenzie F, Townshend S, Slee J, Kiraly-Borri C, Vasudevan A, Hawkins A, Broley S, Schofield L, Verhoef H, Walker CE, Molster C, Blackwell JM, Jamieson S, Tang D, Lassmann T, Mina K, Beilby J, Davis M, Laing N, Murphy L, Weeramanthri T, Dawkins H, Goldblatt J (2016) The rare and undiagnosed diseases diagnostic service – application of massively parallel sequencing in a state-wide clinical service. Orphanet J Rare Dis:11, 77. \nhttps://doi.org/10.1186/s13023-016-0462-7"
    },
    {
      "author": "R Benjamin",
      "first-page": "51",
      "journal-title": "Issues Sci Technol",
      "key": "430_CR8",
      "unstructured": "Benjamin R (2016) Interrogating equity: a disability justice approach to genetic engineering. Issues Sci Technol 32:51",
      "volume": "32",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMp1602010",
      "author": "RJ Blendon",
      "doi-asserted-by": "publisher",
      "first-page": "1406",
      "journal-title": "N Engl J Med",
      "key": "430_CR9",
      "unstructured": "Blendon RJ, Gorski MT, Benson JM (2016) The public and the gene-editing revolution. N Engl J Med 374:1406–1411. \nhttps://doi.org/10.1056/NEJMp1602010",
      "volume": "374",
      "year": "2016"
    },
    {
      "DOI": "10.1002/mgg3.463",
      "author": "FK Boardman",
      "doi-asserted-by": "crossref",
      "first-page": "941",
      "journal-title": "Mol Gen Genomic Med",
      "key": "430_CR10",
      "unstructured": "Boardman FK, Hale R (2018) How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening. Mol Gen Genomic Med 6:941–956",
      "volume": "6",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13023-017-0730-1",
      "author": "KR Bogart",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Orphanet J Rare Dis",
      "key": "430_CR11",
      "unstructured": "Bogart KR, Irvin VL (2017) Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis 12:177. \nhttps://doi.org/10.1186/s13023-017-0730-1",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1089/crispr.2018.0053",
      "author": "Andrea Boggio",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "issue": "3",
      "journal-title": "The CRISPR Journal",
      "key": "430_CR12",
      "unstructured": "Boggio A, Knoppers BM, Almqvist J, Romano C (2019) The human right to science and the regulation of human germline engineering. The CRISPR Journal 2(3). \nhttps://doi.org/10.1089/crispr.2018.0053",
      "volume": "2",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrg3555",
      "author": "KM Boycott",
      "doi-asserted-by": "publisher",
      "first-page": "681",
      "journal-title": "Nat Rev Genet",
      "key": "430_CR13",
      "unstructured": "Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE (2013) Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 14:681–691. \nhttps://doi.org/10.1038/nrg3555",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1089/crispr.2017.0024",
      "author": "C Brokowski",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "The CRISPR Journal",
      "key": "430_CR14",
      "unstructured": "Brokowski C (2018) Do CRISPR germline ethics statements cut it? The CRISPR Journal 1:115–125",
      "volume": "1",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fmed.2019.00157",
      "author": "T Bubela",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "journal-title": "Front Med",
      "key": "430_CR15",
      "unstructured": "Bubela T, Kleiderman E, Master Z, Ogbogu U, Ravitsky V, Zarzeczny A, Knoppers BM (2019) Canada’s Assisted Human Reproduction Act: pragmatic reforms in support of research. Front Med 6:157. \nhttps://doi.org/10.3389/fmed.2019.00157",
      "volume": "6",
      "year": "2019"
    },
    {
      "author": "S Burningham",
      "first-page": "317",
      "journal-title": "Can J Comp Contemp Law",
      "key": "430_CR16",
      "unstructured": "Burningham S (2015) Courts, challenges, and cures: legal avenues for patients with rare diseases to challenge health care decisions. Can J Comp Contemp Law 1:317–350",
      "volume": "1",
      "year": "2015"
    },
    {
      "key": "430_CR17",
      "unstructured": "Canadian Organization for Rare Disorders (CORD) (2012) Canadian Organization for Rare Disorders welcomes announcement of orphan drug framework. \nhttps://www.newswire.ca/news-releases/canadian-organization-for-rare-disorders-welcomes-announcement-of-orphan-drug-framework-510864781.html\n\n. Accessed 6 March 2018"
    },
    {
      "key": "430_CR18",
      "unstructured": "Canadian Organization for Rare Disorders (CORD) (2015) Now is the time: a strategy for rare diseases in a strategy for all Canadians"
    },
    {
      "DOI": "10.1007/s11019-017-9793-y",
      "author": "G Cavaliere",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "issue": "2",
      "journal-title": "Med Health Care Philos",
      "key": "430_CR19",
      "unstructured": "Cavaliere G (2017) Genome editing and assisted reproduction: curing embryos, society or prospective parents? Med Health Care Philos 21(2):215–225. 1-11. \nhttps://doi.org/10.1007/s11019-017-9793-y",
      "volume": "21",
      "year": "2017"
    },
    {
      "author": "A Christianson",
      "key": "430_CR20",
      "unstructured": "Christianson A, Howson CP, Modell B (2006) March of dimes: global report on birth defects: the hidden toll of dying and disabled children. White Plains, New York",
      "volume-title": "March of dimes: global report on birth defects: the hidden toll of dying and disabled children",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMp1710370",
      "author": "G Church",
      "doi-asserted-by": "publisher",
      "first-page": "1909",
      "journal-title": "N Engl J Med",
      "key": "430_CR21",
      "unstructured": "Church G (2017) Compelling reasons for repairing human germlines. N Engl J Med 377:1909–1911. \nhttps://doi.org/10.1056/NEJMp1710370",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1353/ken.1997.0021",
      "doi-asserted-by": "crossref",
      "key": "430_CR22",
      "unstructured": "Council of Europe (1997) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (Oviedo Convention)"
    },
    {
      "key": "430_CR23",
      "unstructured": "Crowe K (2018) Following the money between patient groups and Big Pharma, CBC News. \nhttp://www.cbc.ca/news/health/second-opinion-patient-advocacy-pharmaceutical-industry-funding-drug-prices-1.4539271\n\n. Accessed 8 March 2018"
    },
    {
      "key": "430_CR24",
      "unstructured": "CTV News (2017) 63,000 Canadians left the country for medical treatment last year: Fraser Institute. \nhttps://www.ctvnews.ca/health/63-000-canadians-left-the-country-for-medical-treatment-last-year-fraser-institute-1.3486635\n\n. Accessed 6 March 2018"
    },
    {
      "DOI": "10.1056/NEJMp1711000",
      "author": "B Cwik",
      "doi-asserted-by": "crossref",
      "first-page": "1911",
      "journal-title": "N Engl J Med",
      "key": "430_CR25",
      "unstructured": "Cwik B (2017) Designing ethical trials of germline gene editing. N Engl J Med 377:1911–1913",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nbt.3998",
      "author": "A Dance",
      "doi-asserted-by": "publisher",
      "first-page": "1006",
      "journal-title": "Nat Biotechnol",
      "key": "430_CR26",
      "unstructured": "Dance A (2017) Better beings? Nat Biotechnol 35:1006–1011. \nhttps://doi.org/10.1038/nbt.3998",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1186/1750-1172-9-S1-O31",
      "author": "M de Chalendar",
      "doi-asserted-by": "crossref",
      "first-page": "O31",
      "journal-title": "Orphanet J Rare Dis",
      "key": "430_CR27",
      "unstructured": "de Chalendar M, Daniel M, Olry A, Rath A (2014) Rare diseases and disabilities: improving the information available with three Orphanet projects. Orphanet J Rare Dis 9:O31",
      "volume": "9",
      "year": "2014"
    },
    {
      "author": "I de Lecuona",
      "first-page": "673",
      "journal-title": "Yale J Biol Med",
      "key": "430_CR28",
      "unstructured": "de Lecuona I, Casado M, Marfany G, López-Baroni M, Escarrabill M (2017) Gene editing in humans: towards a global and inclusive debate for responsible research. Yale J Biol Med 90:673–681",
      "volume": "90",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41431-017-0076-0",
      "author": "G De Wert",
      "doi-asserted-by": "publisher",
      "first-page": "445",
      "journal-title": "Eur J Hum Genet",
      "key": "430_CR29",
      "unstructured": "De Wert G et al (2018) Human germline gene editing: recommendations of ESHG and ESHRE. Eur J Hum Genet 26:445–449. \nhttps://doi.org/10.1038/s41431-017-0076-0",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13023-017-0618-0",
      "author": "S Dharssi",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "issue": "1",
      "journal-title": "Orphanet J Rare Dis",
      "key": "430_CR30",
      "unstructured": "Dharssi S, Wong-Rieger D, Harold M, Terry S (2017) Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis 12(1):63. \nhttps://doi.org/10.1186/s13023-017-0618-0",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1136/adc.2010.193664",
      "author": "JA Dodge",
      "doi-asserted-by": "crossref",
      "first-page": "791",
      "journal-title": "Arch Dis Child",
      "key": "430_CR31",
      "unstructured": "Dodge JA, Chigladze T, Donadieu J, Grossman Z, Ramos F, Serlicorni A, Siderius L, Stefanidis CJ, Tasic V, Valiulis A, Wierzba J (2011) The importance of rare diseases: from the gene to society. Arch Dis Child 96:791–792",
      "volume": "96",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s12687-017-0320-x",
      "author": "D Esquivel-Sada",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "journal-title": "J Community Gen",
      "key": "430_CR32",
      "unstructured": "Esquivel-Sada D, Nguyen MT (2018) Diagnosis of rare diseases under focus: impacts for Canadian patients. J Community Gen 9:37–50",
      "volume": "9",
      "year": "2018"
    },
    {
      "key": "430_CR33",
      "unstructured": "European Organisation for Rare Diseases (EURORDIS) (2018)Introduction on the topic of genome editing for rare disease patients. \nhttp://download2.eurordis.org.s3.amazonaws.com/EURORDISIntroductionongenomeeditingforRDpatients.pdf\n\n. Accessed 25 July 2018"
    },
    {
      "key": "430_CR34",
      "unstructured": "European Organisation for Rare Diseases (EURORDIS) (2017) Rare disease patients \u0026 genome editing: perspectives and engagement. \nhttps://arrige.org/EURORDIS_CRISPR_meeting.pdf\n\n. Accessed 25 July 2018"
    },
    {
      "key": "430_CR35",
      "unstructured": "European Parliament, the Council and the Commission (2012) Charter of fundamental rights of the European Union. Official Journal of the European Union. 2012/C 326/02"
    },
    {
      "key": "430_CR36",
      "unstructured": "Federation of European Academies of Medicine (FEAM) (2017) The application of genome editing in humans: a position paper of FEAM - the Federation of European Academics of Medicine. \nhttps://www.feam.eu/wp-content/uploads/HumanGenomeEditingFEAMPositionPaper2017.pdf\n\n. Accessed 15 July 2018"
    },
    {
      "key": "430_CR37",
      "unstructured": "Foht B (2018) Gene editing: too much conversation, Not Enough Action. The Weekly Standard. \nhttps://www.weeklystandard.com/brendan-p-foht/gene-editing-too-much-conversation-not-enough-action\n\n. Accessed 25 June 2018"
    },
    {
      "key": "430_CR38",
      "unstructured": "Forrest M (2017) Health Canada gives ‘kiss of death’ to planned policy for rare-disease drugs. National Post. \nhttp://nationalpost.com/news/politics/health-canada-gives-kiss-of-death-to-planned-policy-for-rare-disease-drugs\n\n. Accessed 25 May 2018"
    },
    {
      "DOI": "10.1038/mt.2015.118",
      "author": "T Friedmann",
      "doi-asserted-by": "publisher",
      "first-page": "1282",
      "journal-title": "Mol Ther",
      "key": "430_CR39",
      "unstructured": "Friedmann T, Jonlin EC, King NMP, Torbett BE, Wivel NA, Kaneda Y, Sadelain M (2015) ASGCT and JSGT joint position statement on human genomic editing. Mol Ther 23:1282. \nhttps://doi.org/10.1038/mt.2015.118",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nbt.3958",
      "author": "G Gaskell",
      "doi-asserted-by": "crossref",
      "first-page": "1021",
      "journal-title": "Nat Biotechnol",
      "key": "430_CR40",
      "unstructured": "Gaskell G, Bard I, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H (2017) Public views on gene editing and its uses. Nat Biotechnol 35:1021–1023",
      "volume": "35",
      "year": "2017"
    },
    {
      "key": "430_CR41",
      "unstructured": "Genetic Alliance UK (2015) Genome editing: what does it mean for patients? \nhttp://www.geneticalliance.org.uk/our-work/medical-research/genome-editing-what-does-it-mean-for-patients/\n\n. Accessed 25 July 2018"
    },
    {
      "author": "UK Genetic Alliance",
      "key": "430_CR42",
      "unstructured": "Genetic Alliance UK (2016) Genome editing technologies: the patient perspective. Genetic Alliance UK, London",
      "volume-title": "Genome editing technologies: the patient perspective",
      "year": "2016"
    },
    {
      "key": "430_CR43",
      "unstructured": "Goldman B (2017) Man Googles rash, discovers he has one-in-a-million rare disease. CBC Radio. \nhttp://www.cbc.ca/radio/whitecoat/man-googles-rash-discovers-he-has-one-in-a-million-disease-1.4339872/man-googles-rash-discovers-he-has-one-in-a-million-rare-disease-1.4339923\n\n. Accessed 25 May 2018"
    },
    {
      "DOI": "10.1002/pd.743",
      "author": "SE Gollust",
      "doi-asserted-by": "crossref",
      "first-page": "1003",
      "journal-title": "Prenat Diagn",
      "key": "430_CR44",
      "unstructured": "Gollust SE, Thompson RE, Gooding HC, Biesecker BB (2003) Living with achondroplasia: attitudes toward population screening and correlation with quality of life. Prenat Diagn 23:1003–1008",
      "volume": "23",
      "year": "2003"
    },
    {
      "DOI": "10.1111/japp.12249",
      "author": "C Gyngell",
      "doi-asserted-by": "crossref",
      "first-page": "498",
      "journal-title": "J Appl Philos",
      "key": "430_CR45",
      "unstructured": "Gyngell C, Douglas T, Savulescu J (2017) The ethics of germline gene editing. J Appl Philos 34:498–513",
      "volume": "34",
      "year": "2017"
    },
    {
      "DOI": "10.1080/15265161.2015.1104163",
      "author": "J Harris",
      "doi-asserted-by": "publisher",
      "first-page": "30",
      "journal-title": "Am J Bioeth",
      "key": "430_CR46",
      "unstructured": "Harris J (2015) Germline manipulation and our future worlds. Am J Bioeth 15:30–34. \nhttps://doi.org/10.1080/15265161.2015.1104163",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1111/bioe.12365",
      "author": "B Hofmann",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "journal-title": "Bioethics",
      "key": "430_CR47",
      "unstructured": "Hofmann B (2017) ‘You are inferior!’ Revisiting the expressivist argument. Bioethics 31:505–514. \nhttps://doi.org/10.1111/bioe.12365",
      "volume": "31",
      "year": "2017"
    },
    {
      "key": "430_CR48",
      "unstructured": "Hough SH, Ajetunmobi A (2017) The future of CRISPR applications in the lab, the clinic and society. In: Precision Medicine, CRISPR, and Genome Engineering. Springer, pp 157–178"
    },
    {
      "DOI": "10.1038/d41586-018-07881-1",
      "author": "JB Hurlbut",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "journal-title": "Nature",
      "key": "430_CR49",
      "unstructured": "Hurlbut JB (2019) Human genome editing: ask whether, not how. Nature 565:135",
      "volume": "565",
      "year": "2019"
    },
    {
      "DOI": "10.1186/1750-1172-7-s2-a32",
      "author": "C Huyard",
      "doi-asserted-by": "publisher",
      "first-page": "A32",
      "journal-title": "Orphanet J Rare Dis",
      "key": "430_CR50",
      "unstructured": "Huyard C (2012) The emergence of the cause of rare diseases and rare disease patients’ movement. Orphanet J Rare Dis 7:A32. \nhttps://doi.org/10.1186/1750-1172-7-s2-a32",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nbt.4000",
      "author": "I Hyun",
      "doi-asserted-by": "crossref",
      "first-page": "1023",
      "journal-title": "Nat Biotechnol",
      "key": "430_CR51",
      "unstructured": "Hyun I, Osborn C (2017) Query the merits of embryo editing for reproductive research now. Nat Biotechnol 35:1023–1025",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1126/science.aad6778",
      "author": "R Isasi",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "journal-title": "Science",
      "key": "430_CR52",
      "unstructured": "Isasi R, Kleiderman E, Knoppers BM (2016) Editing policy to fit the genome? Science 351:337–339",
      "volume": "351",
      "year": "2016"
    },
    {
      "DOI": "10.1002/hast.701",
      "author": "ET Juengst",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "Hast Cent Rep",
      "key": "430_CR53",
      "unstructured": "Juengst ET (2017) Crowdsourcing the moral limits of human gene editing? Hast Cent Rep 47:15–23",
      "volume": "47",
      "year": "2017"
    },
    {
      "DOI": "10.1089/crispr.2018.0040",
      "author": "ET Juengst",
      "doi-asserted-by": "crossref",
      "first-page": "351",
      "journal-title": "CRISPR J",
      "key": "430_CR54",
      "unstructured": "Juengst ET, Henderson GE, Walker RL, Conley JM, MacKay D, Meagher KM, Saylor K, Waltz M, Kuczynski KJ, Cadigan RJ (2018) Is enhancement the price of prevention in human gene editing? CRISPR J 1:351–354",
      "volume": "1",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ajmg.a.38413",
      "author": "L Kempf",
      "doi-asserted-by": "crossref",
      "first-page": "773",
      "journal-title": "Am J Med Genet A",
      "key": "430_CR55",
      "unstructured": "Kempf L, Goldsmith JC, Temple R (2018) Challenges of developing and conducting clinical trials in rare disorders. Am J Med Genet A 176:773–783",
      "volume": "176",
      "year": "2018"
    },
    {
      "author": "P Kitcher",
      "key": "430_CR56",
      "unstructured": "Kitcher P (1996) The live to come: the genetic revolution and human possibilities. Simon \u0026 Schuster, New York, NY",
      "volume-title": "The live to come: the genetic revolution and human possibilities",
      "year": "1996"
    },
    {
      "DOI": "10.1136/medethics-2013-101648",
      "author": "E Kleiderman",
      "doi-asserted-by": "crossref",
      "first-page": "691",
      "journal-title": "J Med Ethics",
      "key": "430_CR57",
      "unstructured": "Kleiderman E, Knoppers BM, Fernandez CV, Boycott KM, Ouellette G, Wong-Rieger D, Adam S, Richer J, Avard D (2014) Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases. J Med Ethics 40:691–696",
      "volume": "40",
      "year": "2014"
    },
    {
      "DOI": "10.1136/medethics-2019-105436",
      "doi-asserted-by": "crossref",
      "key": "430_CR58",
      "unstructured": "Kleiderman E, Ravitsky V, Knoppers BM (2019) The \"serious\" factor in germline modification. Journal of Medical Ethics (in press)"
    },
    {
      "DOI": "10.1002/hast.792",
      "author": "Sigal Klipstein",
      "doi-asserted-by": "crossref",
      "first-page": "S28",
      "journal-title": "Hastings Center Report",
      "key": "430_CR59",
      "unstructured": "Klipstein S (2017) Parenting in the age of preimplantation gene editing. Hastings Center Report 47",
      "volume": "47",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41536-017-0007-2",
      "author": "BM Knoppers",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Npj Regen Med",
      "key": "430_CR60",
      "unstructured": "Knoppers BM et al (2017) Human gene editing: revisiting Canadian policy. Npj Regen Med 2:3. \nhttps://doi.org/10.1038/s41536-017-0007-2",
      "volume": "2",
      "year": "2017"
    },
    {
      "DOI": "10.1503/cmaj.181657",
      "author": "BM Knoppers",
      "doi-asserted-by": "crossref",
      "first-page": "E91",
      "journal-title": "Can Med Assoc J",
      "key": "430_CR61",
      "unstructured": "Knoppers BM, Kleiderman E (2019) “CRISPR babies”: what does this mean for science and Canada? Can Med Assoc J 191:E91–E92",
      "volume": "191",
      "year": "2019"
    },
    {
      "key": "430_CR62",
      "unstructured": "Kolata G, Wee S-L, Belluck P (2018) Chinese scientist claims to use CRISPR to make first genetically edited babies. \nhttps://www.nytimes.com/2018/11/26/health/gene-editing-babies-china.html\n\n. Accessed 13 May 2019"
    },
    {
      "key": "430_CR63",
      "unstructured": "LePage M (2017) Boom in human gene editing as 20 CRISPR trials gear up. New Scientist \nhttps://www.newscientist.com/article/2133095-boom-in-human-gene-editing-as-20-crispr-trials-gear-up/\n\n. Accessed 6 March 2018"
    },
    {
      "DOI": "10.1093/biohorizons/hzw012",
      "author": "EJ Lockyer",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Biosci Horizons: The International Journal of Student Research",
      "key": "430_CR64",
      "unstructured": "Lockyer EJ (2016) The potential of CRISPR-Cas9 for treating genetic disorders. Biosci Horizons: The International Journal of Student Research 9:1–10. \nhttps://doi.org/10.1093/biohorizons/hzw012",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1007/978-3-642-38643-5_5",
      "author": "A Lordemann",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "key": "430_CR65",
      "unstructured": "Lordemann A, Danielsson K, Cheng-Ho Lin J (2014) Innovative funding models for rare diseases. In: Bali RK, Bos L, Gibbons MC, Ibell S (eds) Rare Diseases in the Age of Health 2.0. Springer Berlin Heidelberg, Heidelberg, pp 43–50. \nhttps://doi.org/10.1007/978-3-642-38643-5_5",
      "volume-title": "Rare Diseases in the Age of Health 2.0",
      "year": "2014"
    },
    {
      "key": "430_CR66",
      "unstructured": "Luxner L (2018) #ECRD2018 – genome editing might be ‘cure’ for rare diseases but ethical guidelines needed, panel says. ALS News Today. \nhttps://alsnewstoday.com/2018/05/30/ecrd2018-experts-debate-ethical-aspects-of-genome-editing-for-rare-disease-patients/\n\n. Accessed 25 July 2018"
    },
    {
      "DOI": "10.1038/nature23305",
      "author": "H Ma",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "journal-title": "Nature",
      "key": "430_CR67",
      "unstructured": "Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, Koski A, Ji D, Hayama T, Ahmed R, Darby H, van Dyken C, Li Y, Kang E, Park AR, Kim D, Kim ST, Gong J, Gu Y, Xu X, Battaglia D, Krieg SA, Lee DM, Wu DH, Wolf DP, Heitner SB, Belmonte JCI, Amato P, Kim JS, Kaul S, Mitalipov S (2017) Correction of a pathogenic gene mutation in human embryos. Nature 548:413–419",
      "volume": "548",
      "year": "2017"
    },
    {
      "DOI": "10.1111/febs.13110",
      "author": "Y Ma",
      "doi-asserted-by": "crossref",
      "first-page": "5186",
      "journal-title": "FEBS J",
      "key": "430_CR68",
      "unstructured": "Ma Y, Zhang L, Huang X (2014) Genome modification by CRISPR/Cas9. FEBS J 281:5186–5193",
      "volume": "281",
      "year": "2014"
    },
    {
      "key": "430_CR69",
      "unstructured": "Marchitelli R (2017) Location, location, location: how your health-care coverage is linked to where you live in Canada. CBC News. \nhttp://www.cbc.ca/news/canada/calgary/hearing-impaired-medical-implant-surgery-province-1.4435428\n\n. Accessed 6 March 2018"
    },
    {
      "DOI": "10.1016/j.atg.2014.04.003",
      "author": "D Mascalzoni",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Appl Transl Genomics",
      "key": "430_CR70",
      "unstructured": "Mascalzoni D, Paradiso A, Hansson M (2014) Rare disease research: breaking the privacy barrier. Appl Transl Genomics 3:23–29. \nhttps://doi.org/10.1016/j.atg.2014.04.003",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jogc.2017.08.028",
      "author": "Z Master",
      "doi-asserted-by": "crossref",
      "first-page": "224",
      "journal-title": "J Obstet Gynaecol Can",
      "key": "430_CR71",
      "unstructured": "Master Z, Bedford P (2018) CRISPR gene editing should be allowed in Canada, but under what circumstances? J Obstet Gynaecol Can 40:224–226",
      "volume": "40",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.stem.2016.04.011",
      "author": "T McCaughey",
      "doi-asserted-by": "crossref",
      "first-page": "569",
      "journal-title": "Cell Stem Cell",
      "key": "430_CR72",
      "unstructured": "McCaughey T, Sanfilippo PG, Gooden GEC, Budden DM, Fan L, Fenwick E, Rees G, MacGregor C, Si L, Chen C, Liang HH, Baldwin T, Pébay A, Hewitt AW (2016) A global social media survey of attitudes to human genome editing. Cell Stem Cell 18:569–572",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1007/978-3-642-38643-5_9",
      "author": "L Montini",
      "doi-asserted-by": "publisher",
      "first-page": "83",
      "key": "430_CR73",
      "unstructured": "Montini L (2014) Health 2.0: the power of the internet to raise awareness of rare diseases. In: Bali RK, Bos L, Gibbons MC, Ibell S (eds) Rare diseases in the age of health 2.0. Springer, Heidelberg, pp 83–95. \nhttps://doi.org/10.1007/978-3-642-38643-5_9",
      "volume-title": "Rare diseases in the age of health 2.0",
      "year": "2014"
    },
    {
      "key": "430_CR74",
      "unstructured": "Mullin E (2017) CRISPR in 2018: coming to a human near you. MIT Technology Review. \nhttps://www.technologyreview.com/s/609722/crispr-in-2018-coming-to-a-human-near-you/\n\n. Accessed 6 March 2018"
    },
    {
      "DOI": "10.17226/24623",
      "author": "National Academies of Sciences, Engineering, and Medicine",
      "doi-asserted-by": "publisher",
      "key": "430_CR75",
      "unstructured": "National Academies of Sciences, Engineering, and Medicine (2017) Human genome editing: science, ethics, and governance. The National Academies Press, Washington, D.C. \nhttps://doi.org/10.17226/24623",
      "volume-title": "Human genome editing: science, ethics, and governance",
      "year": "2017"
    },
    {
      "DOI": "10.1353/ken.1998.0011",
      "author": "JL Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "journal-title": "Kennedy Instit Ethics J",
      "key": "430_CR76",
      "unstructured": "Nelson JL (1998) The meaning of the act: reflections on the expressive force of reproductive decision making and policies. Kennedy Instit Ethics J 8:165–182. \nhttps://doi.org/10.1353/ken.1998.0011",
      "volume": "8",
      "year": "1998"
    },
    {
      "author": "S Newman",
      "first-page": "53",
      "key": "430_CR77",
      "unstructured": "Newman S (2014) Rare diseases: the medical and the disability perspectives in the age of 2.0. In: Rajeev KB, Bos L, Gibbons MC, Ibell S (eds) Rare diseases in the age of health 2.0. Springer, Heidelberg, p 53",
      "volume-title": "Rare diseases in the age of health 2.0",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jlb/lsx043",
      "author": "A Nordberg",
      "doi-asserted-by": "crossref",
      "first-page": "35",
      "issue": "1",
      "journal-title": "J Law Biosci",
      "key": "430_CR78",
      "unstructured": "Nordberg A, Minssen T, Holm S, Horst M, Mortensen K, Møller BL (2017) Cutting edges and weaving threads in the gene editing (Я) evolution: reconciling scientific progress with legal, ethical, and social concerns. J Law Biosci 5(1):35–83",
      "volume": "5",
      "year": "2017"
    },
    {
      "author": "Nuffield Council on Bioethics",
      "key": "430_CR79",
      "unstructured": "Nuffield Council on Bioethics (2018) Genome editing and human reproduction: social and ethical issues. Nuffield Council on Bioethics, London",
      "volume-title": "Genome editing and human reproduction: social and ethical issues",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajhg.2017.06.012",
      "author": "KE Ormond",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "journal-title": "Am J Hum Genet",
      "key": "430_CR80",
      "unstructured": "Ormond KE, Mortlock DP, Scholes DT, Bombard Y, Brody LC, Faucett WA, Garrison N’A, Hercher L, Isasi R, Middleton A, Musunuru K, Shriner D, Virani A, Young CE (2017) Human germline genome editing. Am J Hum Genet 101:167–176",
      "volume": "101",
      "year": "2017"
    },
    {
      "key": "430_CR81",
      "unstructured": "Orphan Drug Act (1983) H.R. 5238 (97th)"
    },
    {
      "DOI": "10.1177/0306312710385852",
      "author": "A Panofsky",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "Soc Stud Sci",
      "key": "430_CR82",
      "unstructured": "Panofsky A (2011) Generating sociability to drive science: patient advocacy organizations and genetics research. Soc Stud Sci 41:31–57",
      "volume": "41",
      "year": "2011"
    },
    {
      "DOI": "10.2307/3527746",
      "author": "E Parens",
      "doi-asserted-by": "crossref",
      "first-page": "S1",
      "journal-title": "Hast Cent Rep",
      "key": "430_CR83",
      "unstructured": "Parens E, Asch A (1999) The disability rights critique of prenatal genetic testing (special supplement). Hast Cent Rep 29:S1–S22",
      "volume": "29",
      "year": "1999"
    },
    {
      "author": "E Parens",
      "key": "430_CR84",
      "unstructured": "Parens E, Asch A (2000) Prenatal testing and disability rights. Georgetown University Press, Washington",
      "volume-title": "Prenatal testing and disability rights",
      "year": "2000"
    },
    {
      "DOI": "10.2139/ssrn.2697333",
      "author": "S Polcz",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "issue": "2",
      "journal-title": "J Law Biosci",
      "key": "430_CR85",
      "unstructured": "Polcz S, Lewis A (2016) CRISPR-Cas9 and the non-germline non-controversy. J Law Biosci 3(2):413–425. \nhttps://doi.org/10.2139/ssrn.2697333",
      "volume": "3",
      "year": "2016"
    },
    {
      "key": "430_CR86",
      "unstructured": "Ren F, Labrie Y (2017) Leaving Canada for medical care, 2017. Fraser Institute,"
    },
    {
      "DOI": "10.1056/NEJMms1817082",
      "author": "L Rosenbaum",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "journal-title": "N Engl J Med",
      "key": "430_CR87",
      "unstructured": "Rosenbaum L (2019) The future of gene editing — toward scientific and social consensus. N Engl J Med 380:971–975. \nhttps://doi.org/10.1056/NEJMms1817082",
      "volume": "380",
      "year": "2019"
    },
    {
      "key": "430_CR88",
      "unstructured": "Saunders M (2018) Disability rights activists raise concerns over genetic editing for autism. \nhttps://theglobepost.com/2018/07/10/genetic-editing-autism-disability/\n\n. Accessed 29 May 2019"
    },
    {
      "DOI": "10.1111/1467-8519.00251",
      "author": "J Savulescu",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "journal-title": "Bioethics",
      "key": "430_CR89",
      "unstructured": "Savulescu J (2001) Procreative beneficence: why we should select the best children. Bioethics 15:413–426",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1258/ce.2011.011010",
      "author": "J Savulescu",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Clinical Ethics",
      "key": "430_CR90",
      "unstructured": "Savulescu J, Kahane G (2011) Disability: a welfarist approach. Clinical Ethics 6:45–51",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.aan3708",
      "author": "DA Scheufele",
      "doi-asserted-by": "crossref",
      "first-page": "553",
      "journal-title": "Science",
      "key": "430_CR91",
      "unstructured": "Scheufele DA, Xenos MA, Howell EL, Rose KM, Brossard D, Hardy BW (2017) US attitudes on human genome editing. Science 357:553–554",
      "volume": "357",
      "year": "2017"
    },
    {
      "key": "430_CR92",
      "unstructured": "Scope (2018) The social model of disability: what is it and why is it important? \nhttps://www.scope.org.uk/about-us/our-brand/social-model-of-disability\n\n. Accessed 6 March 2018"
    },
    {
      "DOI": "10.1038/527446a",
      "author": "T Shakespeare",
      "doi-asserted-by": "crossref",
      "first-page": "446",
      "journal-title": "Nature",
      "key": "430_CR93",
      "unstructured": "Shakespeare T (2015) Gene editing: heed disability views. Nature 527:446",
      "volume": "527",
      "year": "2015"
    },
    {
      "DOI": "10.3389/fgene.2017.00040",
      "author": "D So",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Front Genet",
      "key": "430_CR94",
      "unstructured": "So D, Kleiderman E, Touré SB, Joly Y (2017) Disease resistance and the definition of genetic enhancement. Front Genet 8:40. \nhttps://doi.org/10.3389/fgene.2017.00040",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1080/21675511.2015.1083145",
      "author": "D Svenstrup",
      "doi-asserted-by": "crossref",
      "first-page": "e1083145",
      "journal-title": "Rare Diseases",
      "key": "430_CR95",
      "unstructured": "Svenstrup D, Jørgensen HL, Winther O (2015) Rare disease diagnosis: a review of web search, social media and large-scale data-mining approaches. Rare Diseases 3:e1083145",
      "volume": "3",
      "year": "2015"
    },
    {
      "DOI": "10.3389/fgene.2013.00101",
      "author": "S Terry",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Front Genet",
      "key": "430_CR96",
      "unstructured": "Terry S (2013) Disease advocacy organizations catalyze translational research. Front Genet 4:101. \nhttps://doi.org/10.3389/fgene.2013.00101",
      "volume": "4",
      "year": "2013"
    },
    {
      "key": "430_CR97",
      "unstructured": "United Nations Educational, Scientific and Cultural Organization (UNESCO) (1997) Universal declaration on the human genome and human rights"
    },
    {
      "key": "430_CR98",
      "unstructured": "van Mil A, Hopkins H, Kinsella S, on behalf of the Royal Society (2017) Potential uses for genetic technologies: dialogue and engagement research conducted on behalf of the Royal Society"
    },
    {
      "DOI": "10.4324/9780203724149",
      "author": "S Wendell",
      "doi-asserted-by": "crossref",
      "key": "430_CR99",
      "unstructured": "Wendell S (2013) The rejected body: feminist philosophical reflections on disability. Routledge, New York",
      "volume-title": "The rejected body: feminist philosophical reflections on disability",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ajmg.10212",
      "author": "Dorothy C. Wertz",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "issue": "1",
      "journal-title": "American Journal of Medical Genetics",
      "key": "430_CR100",
      "unstructured": "Wertz DC, Knoppers BM (2002) Serious genetic disorders: Can or should they be defined? American Journal of Medical Genetics 108:29–35",
      "volume": "108",
      "year": "2002"
    },
    {
      "DOI": "10.1186/s13023-017-0755-5",
      "author": "D Whicher",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "Orphanet J Rare Dis",
      "key": "430_CR101",
      "unstructured": "Whicher D, Philbin S, Aronson N (2018) An overview of the impact of rare disease characteristics on research methodology. Orphanet J Rare Dis 13:14",
      "volume": "13",
      "year": "2018"
    }
  ],
  "reference-count": 101,
  "references-count": 101,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-019-00430-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Human germline genome editing is illegal in Canada, but could it be desirable for some members of the rare disease community?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "11"
}